| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $30.9M | +39.6% |
| Cost of Revenue | $17.0M | +39.7% |
| Gross Profit | $14.0M | +39.4% |
| R&D Expense | $10.1M | +52.0% |
| SG&A Expense | $16.9M | +22.8% |
| Operating Income | -$22.4M | -24.7% |
| Pre-tax Income | -$24.3M | -39.7% |
| Income Tax | $111K | +136.2% |
| Net Income | -$24.4M | -37.0% |
| EPS (Basic) | -$0.65 | -8.3% |
| EPS (Diluted) | -$0.65 | -8.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.3M | -48.5% |
| Accounts Receivable | $6.4M | -11.5% |
| Current Assets | $29.6M | -41.4% |
| Total Assets | $33.6M | -34.9% |
| Current Liabilities | $19.3M | +38.0% |
| Long-term Debt | $750K | -33.3% |
| Total Liabilities | $32.2M | +14.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.8M | +9.8% |
| Capital Expenditures | $1.4M | +130.4% |
| Investing Cash Flow | -$1.4M | -130.4% |
| Financing Cash Flow | -$1.2M | -103.3% |
| Free Cash Flow | -$18.2M | +5.3% |
| Stockholders' Equity |
| $1.5M |
| -93.8% |